Agilent Technologies Collaborates with Seoul National University - - Chromatography Online
Agilent Technologies Collaborates with Seoul National University

LCGC Asia Pacific eNews

Agilent Technologies (California, USA) is to collaborate with Seoul National University (Seoul, South Korea) to open a new research centre that will support the College of Pharmacy’s New Drug Development Centre.

The new centre aims to conduct drug metabolism studies; research, evaluate, and develop new compounds; understand the remedial effects and toxicity; assess pharmokinetics; and conduct clinical tests for drugs. Agilent will provide bioanalytical instruments and multi-omic systems to the college. The new centre will also be Agilent’s reference site for drug development.

Professor Bong-Jin Lee, dean of the college, said: “The College of Pharmacy at Seoul National University has a long tradition of driving innovation.” He added: "We have been leading Korea's pharmaceutical industry through the strategic use of technology and driving the development of new drugs. As we prepare students for the future, we will push the frontiers of drug development by expanding our research facilities, producing outstanding research, and leading the development of technology. We are pleased to collaborate with Agilent, as our scientists and researchers require the latest, most sophisticated instruments for their work."

Rod Minett, general manager, Life Sciences, South Korea and South Asia-Pacific region, said: "One of the megatrends fuelling life science research is the ageing population." He added: “Through continual research, trials, and developments, we believe that newer, more effective drugs can be developed. As such, Agilent is pleased to support SNU College of Pharmacy's drive to create better drugs for a safer and healthier population."

For more information visit: www.agilent.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:




 

LCGC COLUMNISTS 2014

Column Watch: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments. LATEST: Avoiding Reversed-Phase Chromatography Problems Through Informed Method Development Practices: Choosing the Stationary-Phase Chemistry


Perspectives in Modern HPLC: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: Seven Common Faux Pas in Modern HPLC


MS — The Practical Art: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis


LC Troubleshooting: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: Estimating Resolution for Marginally Separated Peaks


More LCGC Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>


Source: LCGC Asia Pacific eNews,
Click here